Table 2.
Medication Use From Before Implant to 6 Months After Implant Among Patients With Data Through the 6-Month Follow-up Period
| Medication | Overall (N = 9359) | Follow-up | |||
|---|---|---|---|---|---|
| 1 Week (n = 9108) | 1 Month (n = 5389) | 3 Months (n = 7241) | 6 Months (n = 5840) | ||
| ACE inhibitor or ARB | 3562 (38.1) | 2251 (24.7) | 2110 (39.2) | 3625 (50.1) | 3098 (53.0) |
| Amiodarone | 3584 (38.3) | 4371 (48.0) | 2516 (46.7) | 3054 (42.2) | 2313 (39.6) |
| Antiplatelet | 5082 (54.3) | 7184 (78.9) | 4470 (82.9) | 6046 (83.5) | 4722 (80.9) |
| β-Blocker | 5162 (55.2) | 3442 (37.8) | 2997 (55.6) | 4890 (67.5) | 4203 (72.0) |
| Enoxaparin | — | 92 (2.1) | 102 (2.6) | 94 (2.5) | 77 (2.4) |
| Loop diuretic | 8139 (87.0) | 6720 (73.8) | 3662 (68.0) | 4930 (68.1) | 3862 (66.1) |
| Mineralocorticoid receptor antagonist | 3707 (39.6) | 1302 (14.3) | 1694 (31.4) | 2408 (33.3) | 2008 (34.4) |
| Phosphodiesterase inhibitora | 500 (11.1) | 1069 (24.1) | 902 (23.0) | 776 (20.9) | 609 (19.2) |
| Warfarin | 2095 (22.4) | 6516 (71.5) | 4577 (84.9) | 6655 (91.9) | 5347 (91.6) |
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker.
a
The denominator differs because these medications were added to the data collection forms recently.